Today news
The same in other media
ICMR asks states to return rapid antibody test kits, says results not up to mark
Reading now: 631
NEW DELHI : The Indian Council of Medical Research (ICMR), the apex body for medical research in India, on Monday asked states to stop using rapid antibody blood test kits developed by Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics brought from China because of conflicting results.
Issuing a revised advisory to state governments, the ICMR said it has written the state governments to stop using Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics kits. “Coronavirus test results from kits of Guangzhou Wondfo Biotech, Zhuhai Livzon Diagnostics show 'wide variation in their sensitivity," ICMR said.
The apex medical research body asked the states to return the test kits so that it can be to be sent back to the suppliers. States are
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|